I found this comment on Investorhub which sounds true if you think about it now.. Friday, 10/20/17 12:34:05 PM Post # of 79999 If Amerop were truly honest in its intention to acquire "additional" or "all" MSLP stock, Amerop easily could:
File a "Binding Letter of Intent" with a monetary penalty clause for not closing.
- so if Amerop doesn't perform what they say they will in BLOI, Amerop would pay a penalty. This happens often with investors and target companies. Stops the foolishness of trial balloons and wasting time without recouping damages.
Amerop could also just file a legal "Tender Offer" at $1.96 with the clear parameters that they will buy up to X amount of shares or with a minimum threshold of acceptance.
Again very common.
Current MSLP shareholders could choose whether to submit their shares for the tender price or not. If not enough shareholders choose to tender, Amerop could raise their tender offer bid PPS.
Nothing stopping either of these options other than Amerop has clearly choses to release a simple NON-BINDING "expression of Interest" with no credible expectation of performance.
T
What is up with all the volume other than new lows?
M
Victory lap time - I saved people 50% if you sold just 2 months ago when I put a .65 price tasrget on the stock. I will be doing some more work and speaking with the company again to set the next target since we will hit .65 this week. Hopefully there are some assets that are worth something to a buyer. Just have to do the work to figure out what the value of the parts are here since it’s no longer viable on its own.
D
Hang on for the wild ride. MSLP is going to get bought by a company that knows how to market their product. Patience will pay dividends here! Buyout will be 80 to 100 mil. Don't believe, watch and see.
Ryan Drexler , CEO ofmusclepharm $MSLP at the fireside chat talking about shareholder communication and updates we are going to see in the next 60-90 days , ...
Ryan Drexler , CEO ofmusclepharm $MSLP at the fireside chat talking about shareholder communication and updates we are going to see in the next 60-90 days , ...
www.youtube.com
Bullish
M
I posted 2 months ago on this board that the selloff was accelerating while the stock was well above $1.00. I said the stock would fall to $0.65 where is would finally find some support. It appears that I was exactly right with my 70% downside call in just 2 months and got where it would settle only off by 4 cents as it is currently trading at $0.61. I rode the stock from $4.25 to $14.00 and sold most at that time. I held onto a little and sold when it finally hit $2.50.
Doesn't seem to be benefiting yet
https://www.globenewswire.com/news-release/2021/01/06/2154258/0/en/MusclePharm-to-Participate-in-Fireside-Chat-at-the-23rd-Annual-ICR-Conference.html
Friday, 10/20/17 12:34:05 PM
Post # of 79999 If Amerop were truly honest in its intention to acquire "additional" or "all" MSLP stock, Amerop easily could:
File a "Binding Letter of Intent" with a monetary penalty clause for not closing.
- so if Amerop doesn't perform what they say they will in BLOI, Amerop would pay a penalty. This happens often with investors and target companies. Stops the foolishness of trial balloons and wasting time without recouping damages.
Amerop could also just file a legal "Tender Offer" at $1.96 with the clear parameters that they will buy up to X amount of shares or with a minimum threshold of acceptance.
Again very common.
Current MSLP shareholders could choose whether to submit their shares for the tender price or not. If not enough shareholders choose to tender, Amerop could raise their tender offer bid PPS.
Nothing stopping either of these options other than Amerop has clearly choses to release a simple NON-BINDING "expression of Interest" with no credible expectation of performance.
https://www.reddit.com/r/pennystocks/comments/kz62i1/musclepharm_mslp_can_this_former_nutrition/?utm_source=share&utm_medium=ios_app&utm_name=iossmf
https://youtu.be/hIDYI9uQYo8
https://www.globenewswire.com/news-release/2021/01/21/2162237/0/en/MusclePharm-Appoints-Marketing-Executive-to-Its-Board-of-Directors.html